Erin McMenamin on Head and Neck Cancer Treatments

Erin McMenamin, MSN
Published: Thursday, Jun 28, 2012

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative disease.

McMenamin says treatment options for HPV-positive head and neck cancers include similar treatments to other head and neck cancers. Patients may undergo surgical resection. More commonly today, patients may have TransOral Robotic Surgery (TORS). These newer surgeries prevent the deformities caused by older treatments.

Depending on the stage of disease, patients may receive radiation postoperatively as well as chemotherapy. These treatments depend on the stage of disease and whether there is node involvement. Chemotherapy tends to be cisplatin-based, just as would be seen with an HPV-negative tumor.

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative disease.

McMenamin says treatment options for HPV-positive head and neck cancers include similar treatments to other head and neck cancers. Patients may undergo surgical resection. More commonly today, patients may have TransOral Robotic Surgery (TORS). These newer surgeries prevent the deformities caused by older treatments.

Depending on the stage of disease, patients may receive radiation postoperatively as well as chemotherapy. These treatments depend on the stage of disease and whether there is node involvement. Chemotherapy tends to be cisplatin-based, just as would be seen with an HPV-negative tumor.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x